Dr. Santiago Esteva, Head of Clinical Operations at SOM Biotech, will be presenting at the 3rd Annual Clinical Trials Summit that will take place in Barcelona next April 29 and 30. He will be discussing about the relationship of small biotech companies and CROs from SOM’s perspective, highlighting the challenges in selecting a CRO to conduct the …
Category Archives: News
On March 8, 2019, the SOMCT02 clinical trial successfully closed recruitment, marking 100% fulfillment of its targeted number of patients. SOM Biotech is very proud of all the efforts being done by the participating sites, and we are expecting to achieve good results from this clinical trial which will cover a great medical need in …
SOM Biotech has just closed a financing round of 7 million euros led by a holding company belonging to a European family with a long tradition in the pharmaceutical sector which will give the opportunity to get a facilitated access to pharma network. Several of the current partners of SOM Biotech have also taken the …
Today, February 28th, is Rare Disease Day, and SOM Biotech is one with Eurordis in raising awareness of rare diseases through the #ShowYourRare campaign. SOM Biotech Team Rare Disease Day is the international awareness-raising campaign for rare diseases and is celebrated on the last day of February each year. Since Rare Disease Day started in 2008, thousands of …
Findacure‘s Drug Repurposing for Rare Diseases Conference is returning for its sixth consecutive year on February 27, 2019 at the Royal College of Nursing, London. The conference discusses the role that drug repurposing can play in lowering the cost and accelerating the development of rare disease treatments. SOM Biotech is a proud sponsor of the event in …
With the opening of the Postgraduate programs of Biotechnology Business Institute for the school year 2019, SOM Biotech renews its teaching collaboration with the institute that offers specialized Master’s and Postgraduate degrees in International Business Management designed for Life Science degree holders. Biotechnology Business Institute, in educational agreement with the University of Barcelona, is a business school based in …
Starting the year seizing business opportunities, SOM Biotech attended the Biotech Showcase/J.P. Morgan Conference held on January 7-9, 2019 in San Francisco, California. Biotech Showcase is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an opportunity to present to and meet with investors and biopharmaceutical executives during the course …
2018 WAS ANOTHER IMPORTANT YEAR FOR SOM BIOTECH with new rounds of investments, a clinical asset in the pipeline and three new products ready for proof of concept. SOM has been making excellent progress in the past months and we wanted to use this letter as a forum to share how we are leveraging our …
Each year, the SOM Biotech team celebrates Christmas by dining out and doing some fun activities to foster camaraderie. For this year’s activity, the team decided to do a “psychiatry” escape room challenge wherein motivation, leadership and teamwork were tried. It was a great team-building activity that promoted unity among the team members, and a fun way to …
Farmantra, a Barcelona-based corporate finance advisory for life sciences companies specializing in early stage valuations, interim CFO support and fund raising, hosted a panel discussion on early stage value creation at Cal Tip Barcelona on the 29th of November. The discussion was focused on topics such as fund-raising management, early dilution through equity-raising, early licensing of assets, …